Signify Health, Inc. Contracts & Agreements
57 Contracts & Agreements
- Business Finance (5 contracts)
- Business Formation (2)
- Business Operations (1)
- Human Resources (29)
- Mergers & Acquisitions (4)
- Uncategorized (16)
- Form of Signify Health, Inc. Restricted Stock Unit Award Agreement (2 Year Accelerated Vesting) (Filed With SEC on February 27, 2023)
- Agreement and Plan of Merger, dated as of September 2, 2022, by and among CVS Pharmacy, Inc., Noah Merger Sub, Inc. and Signify Health, Inc (Filed With SEC on September 6, 2022)
- Signify Health, Inc. Executive Severance Plan (Filed With SEC on August 1, 2022)
- Form of Signify Health, Inc (Filed With SEC on March 3, 2022)
- Form of Signify Health, Inc. Amended and Restated Notice of Substitute of Non-Statutory Stock Option Grant (2019 Plan Performance-Based) (Filed With SEC on March 3, 2022)
- Amendment No. 1 dated December 31, 2021 to the Equity Appreciation Fee Right Agreement dated December 20, 2019 by and between Cure TopCo, LLC and Collaborative Care Holdings, LLC (Filed With SEC on March 3, 2022)
- Amendment No. 1 dated December 31, 2021 to the 2020 Equity Appreciation Fee Right Agreement dated September 28, 2020 by and between Cure TopCo, LLC and Collaborative Care... (Filed With SEC on March 3, 2022)
- Letter Agreement dated December 31, 2021 by and between Cure TopCo, LLC and Collaborative Care Holdings LLC (Filed With SEC on March 3, 2022)
- Agreement and Plan of Merger, dated as of February 9, 2022, by and among Signify Health, Inc., Carbon Acquisition Corporation, Caravan Health, Inc. and Shareholder Representative... (Filed With SEC on February 10, 2022)
- Form of Support Agreement (Filed With SEC on February 10, 2022)
- Form of Non-Qualified Stock Option Award Agreement Under Signify Health, Inc. 2021 Long-Term Incentive Plan (Filed With SEC on May 12, 2021)
- Form of Restricted Stock Unit Award Agreement Under Signify Health, Inc. 2021 Long-Term Incentive Plan (Filed With SEC on May 12, 2021)
- Description of Securities (Filed With SEC on March 25, 2021)
- Reorganization Agreement, dated as of February 12, 2021, by and among Signify Health, Inc., Cure TopCo, LLC and the other persons and entities party thereto (Filed With SEC on March 25, 2021)
- Tax Receivable Agreement, dated February 12, 2021, by and among Signify Health, Inc. and the other persons and entities party thereto (Filed With SEC on March 25, 2021)
- Form of Signify Health, Inc. Notice of Substitute Non-Statutory Stock Option Grant under the 2019 Equity Incentive Plan (time-vesting) (Filed With SEC on March 25, 2021)
- Form of Signify Health, Inc. Notice of Substitute Non-Statutory Stock Option Grant under the 2019 Equity Incentive Plan (time- and performance-vesting) (Filed With SEC on March 25, 2021)
- Cure Aggregator, LLC Incentive Unit Agreement between Cure TopCo, LLC, Cure Aggregator, LLC and Bradford Kyle Armbrester (time-vesting), dated February 16, 2021 (Filed With SEC on March 25, 2021)
- Cure Aggregator, LLC Incentive Unit Agreement between Cure TopCo, LLC, Cure Aggregator, LLC and Bradford Kyle Armbrester (time-and performance-vesting), dated February 16, 2021 (Filed With SEC on March 25, 2021)
- Cure Aggregator, LLC Incentive Unit Agreement between Cure TopCo, LLC, Cure Aggregator, LLC and Steven Senneff, dated February 16, 2021 (Filed With SEC on March 25, 2021)
- Cure Aggregator, LLC Incentive Unit Agreement between Cure TopCo, LLC, Cure Aggregator, LLC and Tad Kendall, dated February 16, 2021 (Filed With SEC on March 25, 2021)
- Cure TopCo, LLC Amended and Restated Synthetic Equity Plan (Filed With SEC on March 25, 2021)
- Form of Amended and Restated Synthetic LLC Unit Award Agreement (Filed With SEC on March 25, 2021)
- Form of Signify Health, Inc. Non-Employee Director Restricted Stock Unit Award Agreement under the 2021 Long-Term Incentive Plan (Filed With SEC on March 25, 2021)
- Form of Signify Health, Inc. Non-Qualified Stock Option Award Agreement under the 2021 Long-Term Incentive Plan (IPO Grants) (Filed With SEC on March 25, 2021)
- Registration Rights Agreement, dated February 12, 2021, by and among Signify Health, Inc. and the other persons and entities party thereto (Filed With SEC on February 19, 2021)
- Stockholders Agreement, dated as of February 12, 2021, by and among Signify Health, Inc. and New Mountain Partners V (AIV-C), L.P (Filed With SEC on February 19, 2021)
- Third Amended and Restated Limited Liability Company Agreement of Cure TopCo, LLC, dated as of February 12, 2021, by and among Signify Health, Inc., Cure TopCo, LLC and the other... (Filed With SEC on February 19, 2021)
- Cure TopCo, LLC Synthetic Equity Plan (Filed With SEC on February 3, 2021)
- Form of Underwriting Agreement (Filed With SEC on February 2, 2021)
- Form of Third Amended and Restated Limited Liability Company Agreement of Cure TopCo, LLC, to be effective prior to the closing of this offering (Filed With SEC on February 2, 2021)
- Form of Registration Rights Agreement between Signify Health, Inc. and the Continuing Pre-IPO LLC Members (Filed With SEC on February 2, 2021)
- Form of Reorganization Agreement between Signify Health, Inc., Cure TopCo, LLC and the parties named therein (Filed With SEC on February 2, 2021)
- Form of Tax Receivable Agreement between Signify Health, Inc. and the TRA Parties (Filed With SEC on February 2, 2021)
- Form of Stockholders Agreement between Signify Health, Inc. and the Continuing Pre-IPO LLC Members (Filed With SEC on February 2, 2021)
- Form of Signify Health, Inc. Long-Term Incentive Plan (Filed With SEC on February 2, 2021)
- Form of Director and Executive Officer Indemnification Agreement (Filed With SEC on February 2, 2021)
- Form of Signify Health, Inc. Employee Stock Purchase Plan (Filed With SEC on February 2, 2021)
- Signify Health, Inc. Non-Employee Director Compensation Policy (Filed With SEC on February 2, 2021)
- Remedy Partners, Inc. 2019 Equity Incentive Plan (Filed With SEC on January 19, 2021)
- New Remedy Corp. Amended and Restated 2019 Equity Incentive Plan (Filed With SEC on January 19, 2021)
- Form of New Remedy Corp. Notice of Substitute Non-Statutory Stock Option Grant under the 2019 Equity Incentive Plan (Filed With SEC on January 19, 2021)
- Form of Remedy Partners, Inc. Notice of Non-Statutory Stock Option Grant under the 2019 Equity Incentive Plan (Filed With SEC on January 19, 2021)
- Form of Class B Incentive Unit Award and Contribution Agreement between Chloe Ox Holdings, LLC, Chloe Ox Aggregator, LLC and the Grantee (Filed With SEC on January 19, 2021)
- Form of Class B Incentive Unit Award and Contribution Agreement between Chloe Ox Holdings, LLC, Chloe Ox Aggregator, LLC and the Grantee (Filed With SEC on January 19, 2021)
- Class C Incentive Unit Award Agreement between Cure TopCo, LLC, Cure Aggregator, LLC and Tad Kendall dated February 14, 2020 (Filed With SEC on January 19, 2021)
- Form of Class C Incentive Unit Award Agreement between Cure TopCo, LLC, Cure Aggregator, LLC and the Grantee (Filed With SEC on January 19, 2021)
- Class C Incentive Unit Award Agreement between Cure TopCo, LLC, Cure Aggregator, LLC and Bradford Kyle Armbrester, dated February 14, 2020 (Filed With SEC on January 19, 2021)
- Employment Agreement between Chloe Ox Holdings, LLC and Bradford Kyle Armbrester, entered into as of April 23, 2018 (Filed With SEC on January 19, 2021)
- Employment Agreement between Remedy BCPI Partners, LLC and Tad Kendall, entered into as of November 5, 2019 (Filed With SEC on January 19, 2021)
- Employment Agreement between Remedy BPCI Partners, LLC and Steve Senneff, dated February 4, 2019 (Filed With SEC on January 19, 2021)
- Consulting Agreement between Chloe Ox Holdings, LLC and Eir Partners, LLC, effective as of March 7, 2019 (Filed With SEC on January 19, 2021)
- Amendment No. 1 to Consulting Agreement between Cure TopCo, LLC and Eir Partners, LLC, dated as of June 18, 2020 (Filed With SEC on January 19, 2021)
- Board of Managers Appointment Agreement between Chloe Ox Holdings, LLC and Brandon Hull, dated February 9, 2018 (Filed With SEC on January 19, 2021)
- Letter Agreement between Cure TopCo, LLC and Taj Clayton, dated June 28, 2020 (Filed With SEC on January 19, 2021)
- Letter Agreement between Cure TopCo, LLC, Cure Aggregator, LLC and Vivian Riefberg, dated December 22, 2019 (Filed With SEC on January 19, 2021)
- Consulting Agreement between Cure TopCo, LLC and Kevin McNamara, dated November 23, 2020 (Filed With SEC on January 19, 2021)
